专利号:US-8952042-B2 优先权日:2009-08-19 标 题 :FXR (NR1H4) binding and activity modulating compounds 发明人:KREMOSER CLAUS; ABEL ULRICH; STEENECK CHRISTOPH; KINZEL OLAF 权利人:KREMOSER CLAUS; ABEL ULRICH; STEENECK CHRISTOPH; KINZEL OLAF; PHENEX PHARMACEUTICALS AG 摘要:The present invention relates to compounds of formula (1): n nwhere R, A, Q and Z are defined herein, or an enantiomer, diastereomer, tautomer, solvate, prodrug or pharmaceutical acceptable salt thereof. These compounds bind to the NR1H4 receptor (FXR) and act as agonists of the NR1H4 receptor (FXR). The invention further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds, and to a process for the synthesis of said compounds.
专利号:CN-109627235-A 优先权日:2018-11-26 标 题 :A kind of high-energy insensitive energetic compound and its synthesis method
参考文献:10.1055/s-2008-1032180 摘要:Fritsky I, Meyer F, Sachse A, Penkova L, Noël G, Dechert S, Varzatskii O. Efficient Syntheses of Some Versatile 3,5-Bifunctional Pyrazole Building Blocks. Synthesis. 2008 Mar;2008(5):800–6. doi: 10.1055/s-2008-1032180. 参考文献:10.1007/s11030-020-10161-8 摘要:Uygun MT, Amudi K, Turaçlı İD, Menges N. A new synthetic approach for pyrazolo[1,5-a]pyrazine-4(5H)-one derivatives and their antiproliferative effects on lung adenocarcinoma cell line. Mol Divers. 2022 Feb;26(1):113–24. doi: 10.1007/s11030-020-10161-8.